Swedencare AB (publ) Stock Nasdaq Stockholm
Equities
SE0008294078
Pharmaceuticals
Sales 2024 * | 2.68B 246M | Sales 2025 * | 3.01B 277M | Capitalization | 8.67B 797M |
---|---|---|---|---|---|
Net income 2024 * | 225M 20.68M | Net income 2025 * | 356M 32.72M | EV / Sales 2024 * | 3.62 x |
Net Debt 2024 * | 1B 92.3M | Net Debt 2025 * | 496M 45.62M | EV / Sales 2025 * | 3.05 x |
P/E ratio 2024 * |
38.6
x | P/E ratio 2025 * |
24.4
x | Employees | - |
Yield 2024 * |
0.91% | Yield 2025 * |
1.46% | Free-Float | 35.04% |
Latest transcript on Swedencare AB (publ)
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 56 | 13-12-31 | |
Jenny Graflind
DFI | Director of Finance/CFO | 48 | 16-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 65 | 22-12-31 | |
Director/Board Member | 57 | 15-12-31 | |
Director/Board Member | 61 | 18-12-31 |
1st Jan change | Capi. | |
---|---|---|
-22.30% | 68.94B | |
+18.88% | 3.43B | |
-3.62% | 3.22B | |
-2.87% | 1.46B | |
-15.41% | 1.38B | |
-4.30% | 1.26B | |
-27.74% | 1.21B | |
-13.54% | 1.14B | |
-2.99% | 1.02B |